VATRELLA, Alessandro
 Distribuzione geografica
Continente #
AS - Asia 19.453
NA - Nord America 13.935
EU - Europa 4.854
SA - Sud America 885
Continente sconosciuto - Info sul continente non disponibili 482
AF - Africa 153
OC - Oceania 16
Totale 39.778
Nazione #
US - Stati Uniti d'America 13.716
HK - Hong Kong 13.513
SG - Singapore 2.510
IT - Italia 2.006
CN - Cina 1.330
VN - Vietnam 919
UA - Ucraina 687
BR - Brasile 662
DE - Germania 464
RU - Federazione Russa 452
FR - Francia 277
IE - Irlanda 271
TR - Turchia 263
KR - Corea 211
FI - Finlandia 181
SE - Svezia 178
IN - India 157
BD - Bangladesh 150
GB - Regno Unito 111
CA - Canada 88
AR - Argentina 85
MX - Messico 64
IQ - Iraq 56
JP - Giappone 53
TW - Taiwan 49
ZA - Sudafrica 46
NL - Olanda 40
ES - Italia 36
EC - Ecuador 35
AT - Austria 31
CO - Colombia 31
ID - Indonesia 31
PK - Pakistan 28
PL - Polonia 27
UZ - Uzbekistan 26
PH - Filippine 21
VE - Venezuela 21
LT - Lituania 19
TN - Tunisia 19
MA - Marocco 18
MY - Malesia 18
SA - Arabia Saudita 17
AU - Australia 15
DZ - Algeria 15
KE - Kenya 14
CR - Costa Rica 13
JM - Giamaica 13
NP - Nepal 13
PE - Perù 12
PY - Paraguay 12
AZ - Azerbaigian 10
BE - Belgio 10
CL - Cile 10
CZ - Repubblica Ceca 10
EG - Egitto 10
JO - Giordania 9
TT - Trinidad e Tobago 9
UY - Uruguay 9
EU - Europa 8
BG - Bulgaria 7
BH - Bahrain 7
ET - Etiopia 7
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
NI - Nicaragua 6
OM - Oman 6
RO - Romania 6
BO - Bolivia 5
GR - Grecia 5
HN - Honduras 5
IL - Israele 5
LB - Libano 5
PT - Portogallo 5
SV - El Salvador 5
TH - Thailandia 5
AL - Albania 4
KG - Kirghizistan 4
KW - Kuwait 4
NG - Nigeria 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
GY - Guiana 3
HU - Ungheria 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AM - Armenia 2
BZ - Belize 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
IR - Iran 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
PA - Panama 2
RS - Serbia 2
Totale 39.269
Città #
Hong Kong 13.502
Ann Arbor 2.573
Singapore 1.309
Wilmington 1.148
Woodbridge 1.119
San Jose 1.018
Jacksonville 852
Chandler 851
Milan 829
Princeton 753
Ashburn 650
Houston 568
Dallas 567
Dong Ket 397
Beijing 317
Council Bluffs 307
Dublin 266
The Dalles 238
Lauterbourg 233
Izmir 226
Ho Chi Minh City 179
Rome 173
Moscow 169
Andover 166
Nanjing 159
Munich 154
Boardman 141
Dearborn 134
Pellezzano 125
Hanoi 120
Santa Clara 120
Los Angeles 100
Naples 97
Salerno 95
New York 94
Mestre 81
Düsseldorf 65
Fairfield 64
São Paulo 57
Shenyang 54
Hebei 52
Changsha 50
Memphis 50
Figino 48
Tokyo 48
Frankfurt am Main 45
Turin 44
Helsinki 43
Taipei 43
Nanchang 42
Norwalk 41
Jiaxing 39
Columbus 37
Orem 37
Redwood City 35
Pune 34
Tianjin 34
Chicago 32
Montreal 31
Atlanta 29
Johannesburg 29
Nuremberg 29
Seattle 29
Da Nang 27
Mexico City 26
Baghdad 25
Rio de Janeiro 25
Shanghai 25
Boston 24
Brooklyn 24
Haiphong 24
Jinan 24
Dhaka 23
Falls Church 23
Phoenix 23
San Francisco 23
Warsaw 23
Tashkent 22
Denver 21
Stockholm 21
London 20
Manchester 20
Washington 20
Amsterdam 18
Cambridge 18
Florence 18
Mumbai 18
Vienna 18
Chennai 17
Pollena Trocchia 16
Brasília 15
New Delhi 15
Belo Horizonte 14
Bologna 14
Curitiba 14
Guangzhou 14
San Diego 14
Charlotte 13
Turku 13
Buffalo 12
Totale 31.695
Nome #
Omalizumab decreases exacerbation frequency, oral intake of corticosteroids and peripheral blood eosinophils in atopic patients with uncontrolled asthma. 2.389
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 966
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study 895
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications 826
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 703
Surgical approach in thymectomy: Our experience and review of the literature 625
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study 597
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 576
Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma 571
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma 568
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 489
Effects of inhaled beclomethasone dipropionate/formoterol fumarate/glycopyrronium on diaphragmatic workload and lung function in uncontrolled asthma: a case report 484
Effects of statins and farnesyltransferase inhibitors on proliferation and ERK phosphorylation in non-small lung cancer cells. 454
Short-term evaluation of dupilumab effects in patients with severe asthma and nasal polyposis 437
The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine 437
Phenotyping severe asthma: a rationale for biologic therapy 431
Extrathoracic recurrence of type A thymoma 366
Application of Proteomics and Peptidomics to COPD 365
Severe eosinophilic asthma: From the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab 358
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 324
Bone and soft tissue non-Hodgkin lymphoma of the maxillofacial area: report of two cases, literature review and new therapeutic strategies. 321
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 312
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 308
Social Networks, Asthma and Much More.. 299
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 294
Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives 284
Novel Biological Therapies for Severe Asthma Endotypes 244
Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation 238
Asymmetric dimethylarginine (ADMA): Will be or will not be a new revolutionary biomarker of bronchial asthma? 224
Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art 204
Differential expression of RNA-binding proteins in airway epithelium in chronic lung inflammation 186
Role of biologics in severe eosinophilic asthma – focus on reslizumab 185
Age as a risk factor in the occurrence of pneumothorax after transthoracic fine needle biopsy: our experience 180
A case of pulmonary hemangioendothelioma transformed into an epitheliod angiosarcoma. 178
Effects of TGF-beta and budesonide on MAPK phosphorylation, IL-6/IL-11 secretion, and cell proliferation in human lung fibroblasts 178
Respiratory infections and asthma 171
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 171
Vascular remodeling in bronchial mucosa of smokers with and without airway obstruction. 170
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review 167
Angiogenetic and apoptotic process in the airways of symptomatic smokers with and without a contralateral non small cell lung cancer 165
Detection of RAS mutation by pyrosequencing in thyroid cytology samples 165
An Acute Bronchodilator Test with Tiotropium or Salmeterol Does Not Allow a Subdivision of Patients according to Responses 164
Angiogenesis in Bronchial Biopsies of Symptomatic Smokers with and without Lung Cancer 164
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-alpha and Haemophilus influenzae in human bronchial epithelial cells 164
Long-term treatment in pediatric asthma: an update on chemical pharmacotherapy 163
Cushing's like syndrome in typical bronchial carcinoid a case report and review of the literature 161
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 158
Serum eosinophil cationic protein (ECP) as a marker of disease activity and treatment efficacy in seasonal asthma. 158
Allergy in urban elderly population living in Campania region (Southern Italy). A multicenter study 156
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 154
Protective effect of MAPK inhibitors and budesonide against apoptosis induced by TGF- in primary cultures of human bronchial epithelial cells. 153
Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. 152
Asthma: Targeted biological therapies 151
Effects of endothelin-1 on MAPK activation, IL-6 production and cell proliferation in normal human lung fibroblasts 151
[The lung in connectivitis]. 150
Characterization of peripheral subsets of dendritic cells in COPD patients: preliminary data 150
Surgical management of cervico-mediastinal goiters: Our experience and review of the literature 148
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases. 147
Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. 146
[Netilmicin in the treatment of respiratory infections]. 145
An insight into pharmacological and clinical basis of anti-IgE for add-on therapy of severe asthma 145
The role of calcium blockers in asthma prevention and therapy. 144
Climate change and air pollution: Effects on respiratory allergy 144
Small cell lung cancer associated with solitary fibrous tumors of the pleura: A case study and literature review 143
Airway Remodelling in Asthma 142
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 142
Protective effect of levodropropizine against cough induced by inhalation of nebulized distilled water in patients with obstructive lung disease. 141
Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells. 141
The potential of biologics for the treatment of asthma 141
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma. 139
Sirtuin 1 and aging theory for chronic obstructive pulmonary disease 139
Bronchial vascularity in the airways of chronic bronchitis and COPD smokers 138
Inhaled beclomethasone dipropionate (BDP) prevents seasonal changes in atopic asthmatics. 137
Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD. 137
[Heterogeneity of microbial flora responsible for respiratory infections in AIDS]. 137
Exhaled nitric oxide after inhalation of isotonic and hypotonic solutions in healthy subjects. 136
New perspectives in asthma treatment. 136
SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease 136
Asthma-related deaths 136
Allergenic pollen and pollen allergy in Europe 136
Vascular remodelling in COPD airways 134
COPD: Maximization of bronchodilation 134
[A case of pulmonary fibrosis]. 133
Recurrent respiratory infections caused by a double aortic arch: The diagnostic role of spirometry 133
Audit on the appropriateness of integrated COPD management: The "aLT-BPCO" project 133
Cytological diagnosis of the thyroidal nodule: A review 133
Near fatal asthma: Treatment and prevention 132
Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells. 131
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases. 131
[The role of neutrophils in the pathogenesis of chronic pulmonary emphysema]. 131
Negative and Positive Role of Social Network in Asthma Patients 131
Increased activation of p38 MAPK in COPD 130
The effects of adding formoterol (F) and tiotropium (T) on exercise performance and breathlessness in patients with COPD 130
Post-pneumonectomy broncho-pleural fistula successfully closed by open-window thoracostomy associated with V.A.C. therapy. 130
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems 129
Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1α, IFN-α and TGF-β 128
Negative and positive role of social network in asthma patients 128
Pulmonary arterovenous malformation causing hemothorax in a pregnant woman without Osler-Weber-Rendu syndrome 128
Fine-needle cytology in the follow-up of breast carcinoma 127
Update on Effects of Climate Changes on Respiratory Allergy 126
Totale 25.842
Categoria #
all - tutte 110.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.272 0 2 7 18 23 43 25 55 186 163 170 580
2022/20232.072 220 131 61 255 254 465 8 210 308 19 98 43
2023/20241.019 99 130 62 61 60 131 50 101 14 51 41 219
2024/20253.225 69 57 47 99 104 316 422 286 452 183 244 946
2025/202622.023 4.419 5.535 4.182 604 1.183 567 1.828 355 534 1.152 308 1.356
2026/2027469 371 98 0 0 0 0 0 0 0 0 0 0
Totale 39.778